Merit Medicine Announces $2m Seed Round To Transform Employer-sponsored Healthcare With Ai-powered Risk Predictions

By Author: otis
Total Articles: 386
Comment this article

Health IT firm Merit Medicine closed a $2M seed investment sponsored by LiveOak Ventures. CEO Ali Panjwani launched the company in 2022 to use AI to self-funded employer-sponsored health insurance. Due to rising medical expenditures and specialty drug prices, many employers risk rising healthcare costs.

Merit Medicine uses AI to anticipate companies' catastrophic healthcare expenses. Merit Medicine analyzes millions of patient journey data points to produce AI-driven projections for each employer's demographic, enabling them make better healthcare budget decisions.

The company goes beyond industry standard of extrapolating past performance. Merit Medicine improves forecasts by combining its own models and dataset with employer-specific population data. This allows benefits leaders to provide the finest benefits to their employees and increase affordable healthcare access.

LiveOak Ventures' investment head, Mike Marcantonio, lauded Merit Medicine's objective and team's drug pricing, market access, and healthcare data analytics expertise. He noted the company's potential to help self-funded firms manage rising healthcare costs and major financial risks from employee health.

Read More - bit.ly/49yoGXA